Multidose formulation of ready-to-use 177Lu-PSMA-617 in a centralized radiopharmacy set-up

被引：11

作者：

Chakraborty, Sudipta ^{[1
,3
]}

Vimalnath, K. V. ^{[1
]}

Chakravarty, Rubel ^{[1
,3
]}

Sarma, H. D. ^{[2
]}

Dash, Ashutosh ^{[1
,3
]}

机构：

[1] Bhabha Atom Res Ctr, Radiopharmaceut Div, Bombay 400085, Maharashtra, India

[2] Bhabha Atom Res Ctr, Radiat Biol & Hlth Sci Div, Bombay 400085, Maharashtra, India

[3] Homi Bhabha Natl Inst, Bombay 400094, Maharashtra, India

来源：

APPLIED RADIATION AND ISOTOPES | 2018年 / 139卷

关键词：

Prostate cancer; PSMA-617; Lu-177; Multidose formulation; Stability; Shelf-life; RESISTANT PROSTATE-CANCER; RADIOLIGAND THERAPY; RADIONUCLIDE THERAPY;

D O I：

10.1016/j.apradiso.2018.04.033

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

Lutetium-177-labeled PSMA inhibitor has emerged as a promising modality for targeted therapy of prostate carcinoma. A protocol for regular multidose formulation of ready-to-use Lu-177-PSMA-617 has been developed based on detailed and systematic radiochemical investigations. The formulation meets the requirements of clinical use and can be shipped to nuclear medicine centres for administration up to 4 days from the date of formulation. The reported protocol would be useful toward facilitating widespread clinical utilization of (177)LuPSMA-617 in the management of prostate cancer.

引用

收藏

页码：91 / 97

页数：7

相关论文

共 13 条

[1] Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer [J].

Ahmadzadehfar, Hojjat ;

Eppard, Elisabeth ;

Kuerpig, Stefan ;

Fimmers, Rolf ;

Yordanova, Anna ;

Schlenkhoff, Carl Diedrich ;

Gaertner, Florian ;

Rogenhofer, Sebastian ;

Essler, Markus .

ONCOTARGET, 2016, 7 (11) :12477-12488

[2] Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study [J].

Ahmadzadehfar, Hojjat ;

Rahbar, Kambiz ;

Kuerpig, Stefan ;

Boegemann, Martin ;

Claesener, Michael ;

Eppard, Elisabeth ;

Gaertner, Florian ;

Rogenhofer, Sebastian ;

Schaefers, Michael ;

Essler, Markus .

EJNMMI RESEARCH, 2015, 5 :1-8

[3] Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for Clinical Imaging [J].

Amor-Coarasa, Alejandro ;

Sehoendorf, Megan ;

Meckel, Marian ;

Vallabhajosula, Shankar ;

Babich, John W. .

JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (09) :1402-1405

[4] Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer [J].

Benesova, Martina ;

Schaefer, Martin ;

Bauder-Wuest, Ulrike ;

Afshar-Oromieh, Ali ;

Kratochwil, Clemens ;

Mier, Walter ;

Haberkorn, Uwe ;

Kopka, Klaus ;

Eder, Matthias .

JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (06) :914-920

[5] 177Lu-PSMA-617 radioligand therapy and outcome in patients with metastasized castration-resistant prostate cancer [J].

Braeuer, Axel ;

Grubert, Lena Sophie ;

Roll, Wolfgang ;

Schrader, Andres Jan ;

Schaefers, Michael ;

Boegemann, Martin ;

Rahbar, Kambiz .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) :1663-1670

[6] Prospects of medium specific activity 177Lu in targeted therapy of prostate cancer using 177Lu-labeled PSMA inhibitor [J].

Chakraborty, Sudipta ;

Chakravarty, Rubel ;

Shetty, Priyalata ;

Vimalnath, K. V. ;

Sen, Ishita B. ;

Dash, Ashutosh .

JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2016, 59 (09) :364-371

[7] On the practical aspects of large-scale production of 177Lu for peptide receptor radionuclide therapy using direct neutron activation of 176Lu in a medium flux research reactor: the Indian experience [J].

Chakraborty, Sudipta ;

Vimalnath, K. V. ;

Lohar, Sharad P. ;

Shetty, Priyalata ;

Dash, Ashutosh .

JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2014, 302 (01) :233-243

[8]

Dawson M., 2017, BET White Paper, V1, P1

[9]

Kondev F. G., 2003, Nuclear Data Sheets, V98, P801, DOI 10.1006/ndsh.2003.0006

[10] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617 [J].

Kratochwil, Clemens ;

Giesel, Frederik L. ;

Stefanova, Melsa ;

Benesova, Martina ;

Bronzel, Marcus ;

Afshar-Oromieh, Ali ;

Mier, Walter ;

Eder, Matthias ;

Kopka, Klaus ;

Haberkorn, Uwe .

JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) :1170-1176